Leaflet DEXAMETAZONA FOSFAT GALENIKA 4mg / ml solution for injection / infusion


Indicated for: inflammation; cancer; COVID-19

Route of administration: injectable / infusion

Substance: dexamethasone (glucocorticoid)

ATC: H02AB02 (Systemic hormonal preparations, excluding sex hormones and insulins | Corticosteroids for systemic use, plain | Glucocorticoids)

Precautions:
Glaucoma warning
Glaucoma warning

Use caution if you have glaucoma or increased eye pressure.

Hyperglycemia
Hyperglycemia

This medicine may increase blood sugar.

Immunosuppression / infection risk
Immunosuppression / infection risk

This medicine may increase the risk of infections.

Breastfeeding warning
Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning
Pregnancy warning

Use during pregnancy only on medical advice.

Withdrawal / do not stop abruptly
Withdrawal / do not stop abruptly

Do not stop treatment abruptly without medical advice.

Dexamethasone is a potent corticosteroid used to treat a wide range of inflammatory, allergic, and autoimmune conditions. It is also used in the treatment of certain cancers, cerebral edema, septic shock, and for the prevention and treatment of chemotherapy-induced nausea and vomiting.

It works by suppressing the body's inflammatory and immune response, reducing inflammation, swelling, redness, and allergic reactions. It is available in the form of tablets, injectable solutions, eye or nasal drops, and ointments.

Side effects may include weight gain, fluid retention, high blood pressure, hyperglycemia, insomnia, weakened immune system, osteoporosis, or, in rare cases, psychiatric disturbances (anxiety, depression). Long-term use can lead to severe side effects, such as Cushing's syndrome.

Dexamethasone is contraindicated in untreated systemic infections and should be used with caution in patients with diabetes, hypertension, osteoporosis, or gastric ulcers. It is important to take it as prescribed by a doctor, and discontinuation should be done gradually to avoid withdrawal effects.

General data about DEXAMETAZONA FOSFAT GALENIKA 4mg / ml

  • Substance: dexamethasone
  • Date of last drug list: 01-06-2025
  • Commercial code: W71071001
  • Concentration: 4mg / ml
  • Pharmaceutical form: solution for injection / infusion
  • Quantity: 25
  • Product type: generic
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: MEDITRIAL INTERNATIONALS LTD. - BULGARIA
  • Holder: GALENIKA INTERNATIONAL KFT. - UNGARIA
  • Number: 15972/2025/01
  • Shelf life: 3 years-after packaging for sale;after opening-it is used immediately

Concentrations available for dexamethasone

  • 0.1%
  • 0.5mg
  • 0.985mg/g
  • 1.5mg/ml
  • 1mg/ml
  • 20mg
  • 40mg
  • 4mg
  • 4mg/ml
  • 700mcg
  • 8mg
  • 8mg/2ml